Bambusa Therapeutics, Inc.
corporate_fare Company Profile
Bambusa Therapeutics, Inc. (NASDAQ:BBTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for BBTX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 8/10. Across its 3 most recent items scored 7 or higher, the top rating is 8/10, with 2 rated 8 or above. Recent SEC coverage for BBTX spans 4.
Recent high-impact activity:
- RA Capital Buys $46.6M of Bambusa Stock, Anchoring $16 IPO
- Director and 10% Owner Buys $6.0M of Bambusa Stock at $16.00 IPO Price
- Bambusa Prices Upsized $169M IPO at $16 a Share, Debuts on Nasdaq Friday
Short Interest & Short Volume
On November 3, 2026, 41.1% of BBTX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.